TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson¿s disease

Hdl Handle:
http://hdl.handle.net/10147/294572
Title:
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson¿s disease
Authors:
Rayaprolu, Sruti; Mullen, Bianca; Baker, Matt; Lynch, Timothy; Finger, Elizabeth; Seeley, William W; Hatanpaa, Kimmo J; Lomen-Hoerth, Catherine; Kertesz, Andrew; Bigio, Eileen H; Lippa, Carol; Josephs, Keith A; Knopman, David S; White, Charles L III; Caselli, Richard; Mackenzie, Ian R; Miller, Bruce L; Boczarska-Jedynak, Magdalena; Opala, Grzegorz; Krygowska-Wajs, Anna; Barcikowska, Maria; Younkin, Steven G; Petersen, Ronald C; Ertekin-Taner, Nilüfer; Uitti, Ryan J; Meschia, James F; Boylan, Kevin B; Boeve, Bradley F; Graff-Radford, Neill R; Wszolek, Zbigniew K; Dickson, Dennis W; Rademakers, Rosa; Ross, Owen A
Citation:
Molecular Neurodegeneration. 2013 Jun 21;8(1):19
Issue Date:
21-Jun-2013
URI:
http://dx.doi.org/10.1186/1750-1326-8-19; http://hdl.handle.net/10147/294572
Abstract:
Abstract Background A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has been reported to be a genetic risk factor for Alzheimer’s disease by two independent groups (Odds ratio between 2.9-4.5). Given the key role of TREM2 in the effective phagocytosis of apoptotic neuronal cells by microglia, we hypothesized that dysfunction of TREM2 may play a more generalized role in neurodegeneration. With this in mind we set out to assess the genetic association of the Alzheimer’s disease-related risk variant in TREM2 (rs75932628, p.R47H) with other related neurodegenerative disorders. Results The study included 609 patients with frontotemporal dementia, 765 with amyotrophic lateral sclerosis, 1493 with Parkinson’s disease, 772 with progressive supranuclear palsy, 448 with ischemic stroke and 1957 controls subjects free of neurodegenerative disease. A significant association was observed for the TREM2 p.R47H substitution in susceptibility to frontotemporal dementia (OR = 5.06; p-value = 0.001) and Parkinson’s disease (OR = 2.67; p-value = 0.026), while no evidence of association with risk of amyotrophic lateral sclerosis, progressive supranuclear palsy or ischemic stroke was observed. Conclusions Our results suggest that the TREM2 p.R47H substitution is a risk factor for frontotemporal dementia and Parkinson’s disease in addition to Alzheimer’s disease. These findings suggest a more general role for TREM2 dysfunction in neurodegeneration, which could be related to its role in the immune response.
Item Type:
Journal Article

Full metadata record

DC FieldValue Language
dc.contributor.authorRayaprolu, Sruti-
dc.contributor.authorMullen, Bianca-
dc.contributor.authorBaker, Matt-
dc.contributor.authorLynch, Timothy-
dc.contributor.authorFinger, Elizabeth-
dc.contributor.authorSeeley, William W-
dc.contributor.authorHatanpaa, Kimmo J-
dc.contributor.authorLomen-Hoerth, Catherine-
dc.contributor.authorKertesz, Andrew-
dc.contributor.authorBigio, Eileen H-
dc.contributor.authorLippa, Carol-
dc.contributor.authorJosephs, Keith A-
dc.contributor.authorKnopman, David S-
dc.contributor.authorWhite, Charles L III-
dc.contributor.authorCaselli, Richard-
dc.contributor.authorMackenzie, Ian R-
dc.contributor.authorMiller, Bruce L-
dc.contributor.authorBoczarska-Jedynak, Magdalena-
dc.contributor.authorOpala, Grzegorz-
dc.contributor.authorKrygowska-Wajs, Anna-
dc.contributor.authorBarcikowska, Maria-
dc.contributor.authorYounkin, Steven G-
dc.contributor.authorPetersen, Ronald C-
dc.contributor.authorErtekin-Taner, Nilüfer-
dc.contributor.authorUitti, Ryan J-
dc.contributor.authorMeschia, James F-
dc.contributor.authorBoylan, Kevin B-
dc.contributor.authorBoeve, Bradley F-
dc.contributor.authorGraff-Radford, Neill R-
dc.contributor.authorWszolek, Zbigniew K-
dc.contributor.authorDickson, Dennis W-
dc.contributor.authorRademakers, Rosa-
dc.contributor.authorRoss, Owen A-
dc.date.accessioned2013-06-26T08:46:01Z-
dc.date.available2013-06-26T08:46:01Z-
dc.date.issued2013-06-21-
dc.identifier.citationMolecular Neurodegeneration. 2013 Jun 21;8(1):19-
dc.identifier.urihttp://dx.doi.org/10.1186/1750-1326-8-19-
dc.identifier.urihttp://hdl.handle.net/10147/294572-
dc.description.abstractAbstract Background A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has been reported to be a genetic risk factor for Alzheimer’s disease by two independent groups (Odds ratio between 2.9-4.5). Given the key role of TREM2 in the effective phagocytosis of apoptotic neuronal cells by microglia, we hypothesized that dysfunction of TREM2 may play a more generalized role in neurodegeneration. With this in mind we set out to assess the genetic association of the Alzheimer’s disease-related risk variant in TREM2 (rs75932628, p.R47H) with other related neurodegenerative disorders. Results The study included 609 patients with frontotemporal dementia, 765 with amyotrophic lateral sclerosis, 1493 with Parkinson’s disease, 772 with progressive supranuclear palsy, 448 with ischemic stroke and 1957 controls subjects free of neurodegenerative disease. A significant association was observed for the TREM2 p.R47H substitution in susceptibility to frontotemporal dementia (OR = 5.06; p-value = 0.001) and Parkinson’s disease (OR = 2.67; p-value = 0.026), while no evidence of association with risk of amyotrophic lateral sclerosis, progressive supranuclear palsy or ischemic stroke was observed. Conclusions Our results suggest that the TREM2 p.R47H substitution is a risk factor for frontotemporal dementia and Parkinson’s disease in addition to Alzheimer’s disease. These findings suggest a more general role for TREM2 dysfunction in neurodegeneration, which could be related to its role in the immune response.-
dc.titleTREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson¿s disease-
dc.typeJournal Article-
dc.language.rfc3066en-
dc.rights.holderSruti Rayaprolu et al.; licensee BioMed Central Ltd.-
dc.description.statusPeer Reviewed-
dc.date.updated2013-06-25T11:02:46Z-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.